Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term immunology. Found 204 abstracts

no pagination
Yi J, Cheng H, Andrake MD, Dunbrack RL, Roder H, Skalka AM. Mapping the epitope of an inhibitory monoclonal antibody to the C-terminal DNA-binding domain of HIV-1 integrase. The Journal of biological chemistry. 2002 Apr 05;277(14):12164-74.
Yusa S, Catina TL, Campbell KS. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol. 2002 May 15;168(10):5047-57.
Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 2001 Jun 15;61(12):4750-5.
Adams GP, Weiner LM. Radioimmunotherapy of solid tumors: from fairytale to reality. Cancer Biother Radiopharm. 2001 Feb;16(1):9-11.
Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol. 2001 Dec 15;167(12):6834-40.
Campbell KS, Colonna M. Human natural killer cell receptors and signal transduction. Int Rev Immunol. 2001 Jun;20(3-4):333-70.
Campbell MS, Chan GK, Yen TJ. Mitotic checkpoint proteins HsMAD1 and HsMAD2 are associated with nuclear pore complexes in interphase. Journal of cell science. 2001 Mar;114(Pt 5):953-63.
Carson WE, Parihar R, Lindemann MJ, Personeni N, Dierksheide J, Meropol NJ, Baselga J, Caligiuri MA. Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells. Eur J Immunol. 2001 Oct;31(10):3016-25.
De Luca A, Tosolini A, Russo P, Severino A, Baldi A, De Luca L, Cavallotti I, Baldi F, Giordano A, Testa JR, Paggi MG. Cyclin T2a gene maps on human chromosome 2q21. J Histochem Cytochem. 2001 Jun;49(6):693-8.
Gui M, Li J, Wen LJ, Hardy RR, Hayakawa K. TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells. J Immunol. 2001 Dec;167(11):6239-46.
Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001 Jan;19:595-621.
Manchester M, Rall GF. Model Systems: transgenic mouse models for measles pathogenesis. Trends Microbiol. 2001 Jan;9(1):19-23.
McCall AM, Shahied L, Amoroso AR, Horak EM, Simmons HH, Nielson U, Adams GP, Schier R, Marks JD, Weiner LM. Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity. J Immunol. 2001 May 15;166(10):6112-7.
Roederer M, Hardy RR. Frequency difference gating: a multivariate method for identifying subsets that differ between samples. Cytometry. 2001 Sep;45(1):56-64.
Roederer M, Moore W, Treister A, Hardy RR, Herzenberg LA. Probability binning comparison: a metric for quantitating multivariate distribution differences. Cytometry. 2001 Sep;45(1):47-55.
Segal DM, Weiner GJ, Weiner LM. Introduction: bispecific antibodies. J Immunol Methods. 2001 Feb;248(1-2):1-6.
Skok JA, Brown KE, Azuara V, Caparros ML, Baxter J, Takacs K, Dillon N, Gray D, Perry RP, Merkenschlager M, Fisher AG. Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nature immunology. 2001 Sep;2(9):848-54.
Slingluff CL, Yamshchikov G, Neese P, Galavotti H, Eastham S, Engelhard VH, Kittlesen D, Deacon D, Hibbitts S, Grosh WW, Petroni G, Cohen R, Wiernasz C, Patterson JW, Conway BP, Ross WG. Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. Clin Cancer Res. 2001 Oct;7(10):3012-24.
Smith MR, Xie T, Zhou ZZ, Joshi I. Efficacy of treatment with antisense oligonucleotides complementary to immunoglobulin sequences of bcl-2/immunoglobulin fusion transcript in a t(14;18) human lymphoma-scid mouse model. Clin Cancer Res. 2001 Feb;7(2):400-6.
von Mehren M, Arlen P, Gulley J, Rogatko A, Cooper HS, Meropol NJ, Alpaugh RK, Davey M, McLaughlin S, Beard MT, Tsang KY, Schlom J, Weiner LM. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res. 2001 May;7(5):1181-91.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term immunology

immunology Human US Gov't Support-PHS Animal Non-US Gov't Support Mice metabolism genetics Female Cultured Tumor Cells therapeutic use biosynthesis Molecular Sequence Data methods chemistry Amino Acid Sequence Natural Killer Cells cytology erbB-2 Receptor pathology Monoclonal Antibodies drug effects Immunophenotyping Flow Cytometry Protein Binding physiology Neoplasm Antigens Lymphocyte Activation Immunoglobulin Fragments Spleen Kinetics analysis Epitopes Monocytes B-Lymphocyte Subsets Tissue Distribution Cell Lineage Signal Transduction Antibody-Dependent Cell Cytotoxicity Antibody Specificity Survival Analysis Immunologic Receptors pharmacology Middle Age IgG Receptors Tertiary Protein Structure Treatment Outcome Lymphocytes Cultured Cells Membrane Glycoproteins Neoplasms B-Lymphocyte Gene Rearrangement Cancer Vaccines drug therapy Algorithms SCID Mice Peptide Fragments Lymph Nodes Chi-Square Distribution Male Immunologic Cytotoxicity Tests Cell Line Bispecific Antibodies Inbred BALB C Mice Knockout Mice Comparative Study CD Antigens Time Factors classification Fluorescence In Situ Hybridization adverse effects Antibody Affinity T-Lymphocyte Epitopes Immunologic Adjuvants Cytokines B-Lymphocytes Chromosome Mapping Mutation Inbred Strains Mice Melanoma Antigen-Antibody Reactions Synthetic Vaccines Headache Radioimmunotherapy Adult Western Blotting CD4-Positive T-Lymphocytes Cytotoxic T-Lymphocytes Multivariate Analysis toxicity Skeletal Muscle Cyclin-Dependent Kinases diagnostic use Complementarity Determining Regions IgE Receptors Molecular Models Acute Disease Monte Carlo Method Breast Neoplasms Amino Acid Motifs secretion Clinical Trials Polyacrylamide Gel Electrophoresis Mass Spectrometry-Matrix-Assisted Laser Desorption-Ionization Isoleucine Immune System Catalytic Domain Binding Sites Molecular Weight embryology Cyclins Site-Directed Mutagenesis Light-Chain Immunoglobulins src Homology Domains Antibody Binding Sites Developmental Gene Expression Regulation Interleukin-2 T-Lymphocyte Subsets Animal Disease Models Protein-Tyrosine Kinase Bromodeoxyuridine Pain Nuclear Pore Follow-Up Studies growth & development therapy Enzyme-Linked Immunosorbent Assay etiology Immunity Glycoproteins Phosphoproteins Complement Receptors Neoplasm Antibodies Th1 Cells adverse Transformed Cell Line CD45 Antigens Phosphorylation Cell Division Immunoglobulin Genes effects Chimeric Proteins Drug Design Centromere T-Lymphocytes Interphase Catalysis Alanine CD56 Antigens Carcinoembryonic Antigen
Last updated on Thursday, August 02, 2018